Fusion Array

Leukemia & Lymphoma

Screen	FusionArray^TM
Quantification	FusionCount^TM
Mutation	Mutector^TM

FusionArray: AML-HighRisk

Identify AML patients who have a poor response to treatment and a high risk of relapse by molecular tests.

Quantitative Assay
Each targeted translocation listed in the
FusionArray^TM also has a corresponding quantification assay available for monitoring minimal residual disease (MRD).
See FusionCount^TM

Screening Panels
for over 50 translocations

FusionArray ^TM
is a specially designed screening panel for the identification of fusion genes or fusion partners. The tests provide supportive genetic evidence for assessment of high risk patients and valuable information for management of the diseases.

Features
Covers 10-50 translocation variants
Covers common and rare types of translocations

Product Information
We provide test services using the FusionArray^TM platform. Please check the Leukemia / Lymphoma translocation list and use Request Form to select translocations of interest. You may also select one of the Pre-Designed FusionArrays^TM below.

Pre-Designed FusionArray ^TM

FusionArray^TM CML
Subtype CML patient for treatment.

FusionArray^TM APL
Subtype APL patients for treatment.

FusionArray^TM AML-HighRisk
Identify high risk of relapse in AML patients.

Custom FusionAssay^TM

Customers can design their own fusion panel from our Leukemia / Lymphoma list. We will then perform the test using the customized panel.

Custom Panel Design Form

Free trial test

FusionArray^TM APL screening assay is now available
Request a trial test

Home | Company | Products | Services | Contact